SS Innovations International, Inc. reiterated its guidance for the first quarter of 2025 on May 5, 2025, expecting revenue to be between $5.0 million and $5.2 million. The company anticipates reporting its first quarter 2025 financial results around May 15, 2025.
The company also provided an update on its second quarter 2025 order trends, noting strong performance. In April 2025 alone, SS Innovations received orders for 10 SSi Mantra 3 surgical robotic systems.
This continued growth trajectory follows the company's recent uplisting to Nasdaq. Management expressed confidence in maintaining this momentum and achieving new milestones throughout 2025, driven by the increasing adoption of its SSi Mantra 3 system.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.